(Updated - November 7, 2018 7:56 AM EST)

(updated to add analyst comments)Credit Suisse analyst Vamil Divan downgraded Ironwood ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change Downgrades

JPMorgan Downgrades Ironwood Pharmaceuticals (IRWD) to UnderweightNovember 7, 2018 5:10 AM Ironwood Pharmaceuticals (IRWD) PT Lowered to $16 at BarclaysNovember 7, 2018 4:46 AM Ironwood Pharmaceuticals (IRWD) PT Lowered to $17 at BTIGNovember 7, 2018 3:23 AM Ironwood Pharma (IRWD) Misses Q3 EPS by 21cNovember 6, 2018 8:12 AM